Retractable Technologies, Inc. (NYSE:RVP) CEO Buys $22,707.36 in Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw acquired 29,112 shares of the stock in a transaction on Wednesday, January 22nd. The stock was bought at an average cost of $0.78 per share, with a total value of $22,707.36. Following the completion of the transaction, the chief executive officer now owns 15,006,863 shares in the company, valued at $11,705,353.14. This trade represents a 0.19 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Retractable Technologies Stock Up 1.9 %

Shares of RVP traded up $0.01 during midday trading on Thursday, reaching $0.78. 20,388 shares of the stock were exchanged, compared to its average volume of 113,821. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01. The company’s 50 day moving average is $0.67 and its two-hundred day moving average is $0.83. The company has a market capitalization of $23.23 million, a P/E ratio of -1.44 and a beta of 1.94. Retractable Technologies, Inc. has a 52 week low of $0.56 and a 52 week high of $1.34.

Analysts Set New Price Targets

Separately, StockNews.com assumed coverage on shares of Retractable Technologies in a research note on Wednesday. They set a “hold” rating for the company.

Institutional Investors Weigh In On Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC bought a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies as of its most recent SEC filing. Institutional investors and hedge funds own 7.58% of the company’s stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.